Mark Dugall

4.1k citations
206 papers · 2.9k indexed · h-index 29

Mark Dugall

193 papers receiving 2.7k citations

Peers

Mark Dugall
Comparison fields: 5 of 120
  • Internal Medicine 638
  • Molecular Medicine 434
  • Biochemistry 337
  • Complementary and alternative medicine 322
  • Pharmacology 485
Replace M R Cesarone with:
M R Cesarone Italy
Gianni Belcaro Italy
Gianni Belcaro Italy
E. Ippolito Italy
L Pellegrini Italy
Umberto Cornelli Italy
G Belcaro Italy
Yan Yang China
L. Incandela Italy
Francesca Santilli Italy
Mark Dugall relative to M R Cesarone Italy M R Cesarone's profile →
Citations per field
00.5×1.5×
M R Cesarone · 1×
Citations per year

Countries citing papers authored by Mark Dugall

Since Specialization
Citations

This map shows the geographic impact of Mark Dugall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Dugall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Dugall more than expected).

Fields of papers citing papers by Mark Dugall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Dugall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Dugall. The network helps show where Mark Dugall may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark Dugall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Dugall Line = papers co-authored together Mark Dugall links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20231
3 20230
4 20220
5 20211
6 20207
7 201914
8 20186
9
Effectiveness of a novel boswellic acids delivery form (Casperome®) in the management of grade II ankle sprains due to sport trauma - a registry study.
20174
10
Superficial venous incompetence: low-cost outpatient minisurgery, sclerotherapy and combined procedure as a management plan. Costs and efficacy. A 20-year, follow-up registry.
20162
11
Aescin-based topical formulation to prevent foot wounds and ulcerations in diabetic microangiopathy.
20163
12
Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study.
20155
13
Pycnogenol® and Centella Asiatica for asymptomatic atherosclerosis progression.
201415
14
Evaluation of the effects of supplementation with Pycnogenol® on fitness in normal subjects with the Army Physical Fitness Test and in performances of athletes in the 100-minute triathlon.
20139
15 200936
16 200837
17 200633
18 20036
19 200349
20 200220

About Mark Dugall

Mark Dugall is a scholar working on Internal Medicine, Complementary and alternative medicine and Neurology, having authored 206 papers that have together received 2.9k indexed citations. Recurring topics across this work include Diagnosis and Treatment of Venous Diseases (61 papers), Venous Thromboembolism Diagnosis and Management (53 papers), Thermoregulation and physiological responses (15 papers), Peripheral Artery Disease Management (13 papers), Pharmacological Effects of Medicinal Plants (12 papers), Neurological Disorders and Treatments (11 papers), Bee Products Chemical Analysis (9 papers) and Dermatologic Treatments and Research (9 papers). The work is most often cited by research in Internal Medicine (638 citations), Molecular Medicine (434 citations) and Biochemistry (337 citations). Mark Dugall has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include M R Cesarone, Gianni Belcaro, Gianni Belcaro, E. Ippolito, L Pellegrini, A. Ricci, Andrea Ledda, Beatrice Feragalli, A Ledda and Umberto Cornelli. Their work appears in journals such as Journal of Cardiovascular Pharmacology and Therapeutics, Phytotherapy Research, Angiology, Evidence-based Complementary and Alternative Medicine and Panminerva Medica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026